Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Blø

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BMC Biotechnology|February 27, 2008
Enhanced gene expression from retroviral vectorsMagnus Blø, David R Micklem, James B Lorens
Expert Opinion on Drug Discovery|March 15, 2013
Drug target discovery using retrovirusesMagnus Blø, David R Micklem, James B Lorens
DNA and Cell Biology|September 11, 2007
Expanding the spectrum of genetic elements transferable by retroviral vectorsMagnus Blø, Jakob M Bogenberger, Susan E Swift, et al.
Oral Oncology|October 29, 2011
S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrestDipak Sapkota, Daniela Elena Costea, Magnus Blø, et al.
Frontiers in Immunology|November 19, 2024
Targeting AXL cellular networks in kidney fibrosisSturla M Grøndal, Magnus Blø, Linn I H Nilsson, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Physiological Reports|December 8, 2021
AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice modelTony J Chen, Piotr Mydel, Małgorzata Benedyk-Machaczka, et al.
Frontiers in Immunology|May 31, 2024
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASHSturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, et al.
Science Signaling|December 17, 2024
AXL-TBK1 driven AKT3 activation promotes metastasisEmily N Arner, Dina Alzhanova, Jill M Westcott, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BMC Biotechnology|February 27, 2008
Enhanced gene expression from retroviral vectorsMagnus Blø, David R Micklem, James B Lorens
Expert Opinion on Drug Discovery|March 15, 2013
Drug target discovery using retrovirusesMagnus Blø, David R Micklem, James B Lorens
DNA and Cell Biology|September 11, 2007
Expanding the spectrum of genetic elements transferable by retroviral vectorsMagnus Blø, Jakob M Bogenberger, Susan E Swift, et al.
Oral Oncology|October 29, 2011
S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrestDipak Sapkota, Daniela Elena Costea, Magnus Blø, et al.
Frontiers in Immunology|November 19, 2024
Targeting AXL cellular networks in kidney fibrosisSturla M Grøndal, Magnus Blø, Linn I H Nilsson, et al.
BMC Biotechnology|June 23, 2014
Flow cytometry-based functional selection of RNA interference triggers for efficient epi-allelic analysis of therapeutic targetsDavid R Micklem, Magnus Blø, Petra Bergström, et al.
Physiological Reports|December 8, 2021
AXL targeting by a specific small molecule or monoclonal antibody inhibits renal cell carcinoma progression in an orthotopic mice modelTony J Chen, Piotr Mydel, Małgorzata Benedyk-Machaczka, et al.
Frontiers in Immunology|May 31, 2024
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASHSturla Magnus Grøndal, Anna Tutusaus, Loreto Boix, et al.
Science Signaling|December 17, 2024
AXL-TBK1 driven AKT3 activation promotes metastasisEmily N Arner, Dina Alzhanova, Jill M Westcott, et al.
Pageof 1